Insights

Alice Epitropoulos, MD, and Laura M. Periman, MD, discuss comprehensive dry eye diagnosis.and management, covering key diagnostic tests, new therapies, and future advancements.

Judy Kim, MD and Peter Kaiser, MD present a comprehensive discussion on evolving therapeutic strategies for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), addressing barriers like step therapy, discuss the potential use of biosimilars, along with the efficacy and safety of newer therapies such as faricimab and high-dose aflibercept.

Retina specialists discuss 2-year data updates in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials for wet macular degeneration (wet AMD) and diabetic macular edema (DME).

Retina specialists, Carl D. Regillo, MD, FACS, FASRS, and Jennifer I. Lim, MD, FARVO, FASRS, provide key insights on biosimilars, overcoming barriers to biosimilar uptake, and the impact of biosimilars on retinal eye disorders.

Intravitreal injection experts share methods of providing safe and effective Intravitreal injections.

Experts discuss collaboration between ophthalmologists and optometrists in the management of patients with retinal eye disease.

Cynthia Matossian, MD, FACS, educates on the impact of dry eye flares on eyesight, as well as treatment therapies.